Skip to main content
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Rankings
Pricing
Log In
Start Free Trial
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Rankings
Pricing
Log In
Start Free Trial
Gerard M.J. Bos
Sign up to set email alerts
269
Publications
6,706
Citation Statements Received
9,038
Citation Statements Given
How they've been cited
9,238
281
6,390
35
How they cite others
7,873
405
8,579
54
Affiliations
Maastricht University Medical Centre
,
Maastricht University
Publications
Order By: Most citations
Bortezomib Induction and Maintenance Treatment in Patients With Newly Diagnosed Multiple Myeloma: Results of the Randomized Phase III HOVON-65/ GMMG-HD4 Trial
Sonneveld
1
,
Schmidt‐Wolf
2
,
van der Holt
3
et al.
2012
JCO
Abstract
Show
832
30
711
2
2
Get access via publisher
Add to collection
Cite
Hyperhomocysteinemia as a Risk Factor for Deep-Vein Thrombosis
den Heijer
1
,
Koster
2
,
Blom
3
et al.
1996
N Engl J Med
Abstract
Show
1,041
12
493
5
Get access via publisher
Add to collection
Cite
Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study
Cavo
1
,
Gay
2
,
Beksaç
3
et al.
2020
The Lancet Haematology
394
8
333
0
3
Get access via publisher
Add to collection
Cite
Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy
Gong
1
,
Klein Wolterink
2
,
Wang
3
et al.
2021
J Hematol Oncol
Abstract
Show
400
1
298
0
Get access via publisher
Add to collection
Cite
Visualising the invisible: a network approach to reveal the informal social side of student learning
Hommes
1
,
Rienties
2
,
de Grave
3
et al.
2012
Adv in Health Sci Educ
Abstract
Show
184
21
251
5
Get access via publisher
Add to collection
Cite
A randomized phase 3 study on the effect of thalidomide combined with adriamycin, dexamethasone, and high-dose melphalan, followed by thalidomide maintenance in patients with multiple myeloma
Lokhorst
1
,
van der Holt
2
,
Zweegman
3
et al.
2010
Abstract
Show
274
11
222
2
Get access via publisher
Add to collection
Cite
Bortezomib before and after high-dose therapy in myeloma: long-term results from the phase III HOVON-65/GMMG-HD4 trial
Goldschmidt
1
,
Lokhorst
2
,
Elias
3
et al.
2017
Leukemia
Abstract
Show
202
11
177
2
Get access via publisher
Add to collection
Cite
Hyperhomocysteinemia and Venous Thrombosis: A Meta-analysis
Heijer
1
,
Rosendaal
2
,
Blom
3
et al.
1998
Thromb Haemost
Abstract
Show
378
4
159
1
Get access via publisher
Add to collection
Cite
1
2
3
4
5